These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Germ cell tumor AND PSA
170 results:

  • 1. Successful management of pre-existing psoriatic arthritis through targeting the IL-23/IL-17 axis in cancer patients receiving immune checkpoint inhibitor therapy: a case series.
    Li YJ; Msaouel P; Campbell M; Hwu P; Diab A; Kim ST
    RMD Open; 2024 Aug; 10(3):. PubMed ID: 39214611
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Upgrading of Grade Group 1 Prostate Cancer at Prostatectomy: germline Risk Factors in a Prospective Cohort.
    Liss MA; Zeltser N; Zheng Y; Lopez C; Liu M; Patel Y; Yamaguchi TN; Eng SE; Tian M; Semmes OJ; Lin DW; Brooks JD; Wei JT; Klein EA; Tewari AK; Mosquera JM; Khani F; Robinson BD; Aasad M; Troyer DA; Kagan J; Sanda MG; Thompson IM; Boutros PC; Leach RJ
    Cancer Epidemiol Biomarkers Prev; 2024 Nov; 33(11):1500-1511. PubMed ID: 39158404
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Primary Paraganglioma of the Prostate: A Systematic Review of the Literature for A Rare Entity.
    Giannakodimos I; Ziogou A; Giannakodimos A; Mitakidi E; Tzelepis K; Fragkiadis E; Charalampakis N
    Rev Recent Clin Trials; 2024; 19(3):189-195. PubMed ID: 38549519
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Primary Well-Differentiated Neuroendocrine tumor/Carcinoid of the Prostate: Case Report and Review of Literature.
    Alhamar M; Sethi S; Reuter VE; Fine SW
    Int J Surg Pathol; 2024 Oct; 32(7):1374-1378. PubMed ID: 38303155
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Multivariate Mendelian randomization provides no evidence for causal associations among both psoriasis and psoriatic arthritis, and skin cancer.
    Yu N; Wang J; Liu Y; Guo Y
    Front Immunol; 2023; 14():1252720. PubMed ID: 37795084
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Clinical, pathologic, and molecular features of amphicrine prostate cancer.
    Graham LS; Haffner MC; Sayar E; Gawne A; Schweizer MT; Pritchard CC; Coleman I; Nelson PS; Yu EY
    Prostate; 2023 May; 83(7):641-648. PubMed ID: 36779357
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Addressing the need for more therapeutic options in neuroendocrine prostate cancer.
    Kemble J; Kwon ED; Karnes RJ
    Expert Rev Anticancer Ther; 2023 Feb; 23(2):177-185. PubMed ID: 36698089
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Economic Evaluation of Three BRAF + MEK Inhibitors for the Treatment of Advanced Unresectable Melanoma With BRAF Mutation From a US Payer Perspective.
    Halloush S; Alkhatib NS; Almutairi AR; Calamia M; Halawah H; Obeng-Kusi M; Hoyle M; Rashdan O; Koeller J; Abraham I
    Ann Pharmacother; 2023 Sep; 57(9):1016-1024. PubMed ID: 36639851
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Cutaneous melanoma, prostate-specific antigen testing and the subsequent risk of prostate cancer diagnosis: a prospective analysis of the 45 and Up Study.
    Egger S; Smith DP; Patel MI; Kimlin MG; Armstrong BK; Nair-Shalliker V
    Br J Cancer; 2023 Jan; 128(1):71-79. PubMed ID: 36319848
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Polysialic Acid Sustains the Hypoxia-Induced Migration and Undifferentiated State of Human Glioblastoma cells.
    Rosa P; Scibetta S; Pepe G; Mangino G; Capocci L; Moons SJ; Boltje TJ; Fazi F; Petrozza V; Di Pardo A; Maglione V; Calogero A
    Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36076963
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. A phase 2 trial of avelumab in men with aggressive-variant or neuroendocrine prostate cancer.
    Brown LC; Halabi S; Somarelli JA; Humeniuk M; Wu Y; Oyekunle T; Howard L; Huang J; Anand M; Davies C; Patel P; Staats J; Weinhold KJ; Harrison MR; Zhang T; George DJ; Armstrong AJ
    Prostate Cancer Prostatic Dis; 2022 Apr; 25(4):762-769. PubMed ID: 35292724
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Prostatic Schwannoma Presenting with Prostate-specific Antigen Elevation: A Case Report.
    Lai BCH; Shih HJ; Syu SH; Lin KH
    Yale J Biol Med; 2021 Dec; 94(4):609-612. PubMed ID: 34970099
    [No Abstract]    [Full Text] [Related]  

  • 13. Neuroendocrine Carcinoma as an Independent Prognostic Factor for Patients With Prostate Cancer: A Population-Based Study.
    Yao J; Liu Y; Liang X; Shao J; Zhang Y; Yang J; Zheng M
    Front Endocrinol (Lausanne); 2021; 12():778758. PubMed ID: 34956090
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Clinicopathological and genetic analyses of small cell neuroendocrine carcinoma of the prostate: Histological features for accurate diagnosis and toward future novel therapies.
    Ida A; Okubo Y; Kasajima R; Washimi K; Sato S; Yoshioka E; Osaka K; Suzuki T; Yamamoto Y; Yokose T; Kishida T; Miyagi Y
    Pathol Res Pract; 2022 Jan; 229():153731. PubMed ID: 34952423
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. [Diagnosis and treatment of small cell neuroendocrine carcinoma of the prostate].
    Zhang M; Shi W; Zhang QW; Wang W; Li QY
    Zhonghua Nan Ke Xue; 2021 Mar; 27(3):219-225. PubMed ID: 34914303
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Route of intracellular uptake and cytotoxicity of sesamol, sesamin, and sesamolin in human melanoma SK-MEL-2 cells.
    Srisongkram T; Weerapreeyakul N
    Biomed Pharmacother; 2022 Feb; 146():112528. PubMed ID: 34906777
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Prostatic tissue: an unexpected finding in a mature ovarian teratoma : Case report and systematic literature review.
    Pecorella I; Framarino Dei Malatesta ML; Riganelli L; Ciardi G; Porpora MG
    Arch Gynecol Obstet; 2022 Apr; 305(4):969-976. PubMed ID: 34618214
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. PAQR6 Upregulation Is Associated with AR Signaling and Unfavorite Prognosis in Prostate Cancers.
    Yang M; Li JC; Tao C; Wu S; Liu B; Shu Q; Li B; Zhu R
    Biomolecules; 2021 Sep; 11(9):. PubMed ID: 34572596
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Association of intraductal carcinoma of the prostate detected by initial histological specimen and neuroendocrine prostate cancer: A report of three cases.
    Ikeda J; Ohe C; Ohsugi H; Matsuda T; Tsuta K; Kinoshita H
    Pathol Int; 2021 Sep; 71(9):621-626. PubMed ID: 34297443
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Somatic-Type Yolk Sac tumor Arising as a Predominant Component of Bladder Urothelial Carcinoma.
    Collins K; Alkashash AM; Hwang M; Kaimakliotis HZ; Cheng L; Idrees MT
    Int J Surg Pathol; 2022 Apr; 30(2):207-213. PubMed ID: 34255554
    [TBL] [Abstract] [Full Text] [Related]  

    [Next]

    of 9.